Victoza® LEAD Clinical Trial Program

Victoza® studies included nearly 4000 patients in the Liraglutide Effect and Action in Diabetes (LEAD) trials. Click here for more information.

Related Content:

Retail
Expert: Data from Opioid-Related Activities in Academic Pharmacy Show the Value of Pharmacists’ Efforts to Fight the Opioid Epidemic
The 3 Insights Guiding John O'Brien and NPC
Expert: Studies Assessing Psilocybin Show Patients Experience Improved Diet, Increased Exercise, Overall Positive Sense of Wellbeing